Cargando…
Current Evidence of the Oncological Benefit-Risk Profile of Hormone Replacement Therapy
Hormone replacement therapy (HRT) remains the most effective treatment for menopausal symptoms and has been shown to prevent bone loss and fracture. The progestogen is added to provide endometrial protection in women with an intact uterus. After the publication of the initial WHI (Women’s Health Ini...
Autores principales: | D’Alonzo, Marta, Bounous, Valentina Elisabetta, Villa, Michela, Biglia, Nicoletta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780494/ https://www.ncbi.nlm.nih.gov/pubmed/31500261 http://dx.doi.org/10.3390/medicina55090573 |
Ejemplares similares
-
Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023) -
The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study
por: Villasco, Andrea, et al.
Publicado: (2021) -
Prognostic Factors Research in Breast Cancer Patients: New Paths
por: Susini, Tommaso, et al.
Publicado: (2022) -
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update
por: Biglia, Nicoletta, et al.
Publicado: (2019) -
Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer patients
por: Villasco, Andrea, et al.
Publicado: (2021)